AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimee M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Kiama Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimee M 2mg/500mg Tablet ER

Diabetic patients using Glimee M 2mg/500mg Extended-Release tablets should understand this medication's classification as an anti-diabetic combination therapy for adult type 2 diabetes. Its purpose is to regulate blood glucose. Administer this medicine with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb impairment. This medication is only one element of a comprehensive diabetes management plan, encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should consult their physician prior to commencement. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and supplementary blood tests to assess blood cell counts and liver function may be recommended by your healthcare provider.

Uses of Glimee M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimee M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimee M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Glimee M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimee M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume the Glimee M 2mg/500mg Extended-Release tablet with food.

How Glimee M 2mg/500mg Tablet ER works:

Glimee M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimepiride and Metformin extended-release tablets (2mg/500mg) with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimee M 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimepiride/Metformin 2mg/500mg tablets (Glimee M) are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimee M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimee M 2mg/500mg Extended-Release tablets. Physician consultation is advised. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimee M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimee M 2mg/500mg Tablet ER :

Should you forget a Glimee M 2mg/500mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.

Facts to Know About Glimee M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimee M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimee M 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimee M 2mg/500mg Tablet ER and seek immediate medical attention.
Glimee M 2mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimepiride/Metformin 2mg/500mg extended-release tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach upset, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimepiride/Metformin ER tablets (2mg/500mg) can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Glimepiride/Metformin (Glimee M 2mg/500mg ER) can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimepiride/Metformin ER tablets (2mg/500mg) with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimee M 2mg/500mg Tablet...
54
MRP 66
18% off